Have a question?
Open from 8am to 7pm Monday to FridayCall customer services
0345 54 32 600

Prices delayed by at least 15 minutes | Print

Ark Invest Ucits Icav ARK GENOMIC REVOLUTION UCITS ETF (ARKG)

Sell: $5.152|Buy: $5.164|Change: 0.01 (-0.26%)

Open

$4.996

Previous close

$5.1715

Trade high

$5.155

Income frequency

Year low

$3.25

Year high

$6.466

Replication method

NOT Applicable

Volume

2,441

Type

ETF

UCITS

Yes

Dividend yield

–

Ongoing charge

0.75

ISIN

IE000O5M6XO1

This share can be held in a Dealing account

Share price

Asset allocation

Top 10 holdings

Holdings 01/04/2026	% of assets
Twist Bioscience Corp	9.74
CRISPR Therapeutics AG	8.55
Tempus AI Inc Class A common stock	8.10
Beam Therapeutics Inc	5.31
10x Genomics Inc Ordinary Shares - Class A	5.19
Natera Inc	4.65
Illumina Inc	4.64
Intellia Therapeutics Inc	4.53
Personalis Inc	4.52
CareDx Inc	3.87

Performance 31/03/2026

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann

	Total return (%)
Fund	- 0.26
Category	-
More...

Investment objective

The investment objective of the Fund is to generate long term capital growth (5 years or more). The Fund uses an active investment management strategy to achieve the Fund’s investment objective. The Fund will invest, under normal circumstances, primarily in global equity securities of companies across multiple sectors

Sustainability Label

This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Learn more about SDR.

Asset class

ETF

Morningstar rating^TM

Morningstar sustainability rating^TM

Morningstar Medalist Rating^TM

Morningstar analyst document

Morningstar report document

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.